Španělsko - španělština - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

viatris pharmaceuticals, s.l.u. - omeprazol - cÁpsula dura gastrorresistente - 20 mg - omeprazol 20 mg - omeprazol

Španělsko - španělština - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

viatris pharmaceuticals, s.l.u. - duloxetina - cÁpsula dura gastrorresistente - 30 mg - duloxetina 30 mg - duloxetina

Španělsko - španělština - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

viatris pharmaceuticals, s.l.u. - duloxetina - cÁpsula dura gastrorresistente - 60 mg - duloxetina 60 mg - duloxetina

Evropská unie - dánština - EMA (European Medicines Agency)

viatris limited - pirfenidon - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunosuppressiva - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Evropská unie - finština - EMA (European Medicines Agency)

viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunosuppressantit - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Evropská unie - švédština - EMA (European Medicines Agency)

viatris limited - pirfenidon - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunsuppressiva - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Evropská unie - bulharština - EMA (European Medicines Agency)

viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - Имуносупресори - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Evropská unie - lotyština - EMA (European Medicines Agency)

viatris limited - pirfenidons - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - imūnsupresanti - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Evropská unie - rumunština - EMA (European Medicines Agency)

viatris limited - pirfenidonă - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - imunosupresoare - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Evropská unie - polština - EMA (European Medicines Agency)

viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - leki immunosupresyjne - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).